Abstract Experimental autoimmune encephalomyelitis (EAE) is an autoimmune demyelinating disease that can be induced in a variety of animal species and which is commonly used as an animal model of multiple sclerosis. In rodent EAE models, the clinical disease is typified by ascending paralysis; however, other clinical patterns can also be observed by inducing disease with particular peptides of myelin proteolipid protein (PLP) or myelin oligodendrocyte glycoprotein. Here we describe EAE induced in C3H/HeJ mice by inoculation with residues 190-209 of PLP. This form of EAE is manifested clinically by a movement disorder, with axial rotation of the head and trunk. Histologically, this form of EAE is characterized by predominant cerebellar or brain stem involvement, depending on whether EAE is induced by active immunization with the PLP peptide, or by passive transfer of T cells specific for the peptide. The inflammatory cell infiltrate is composed of polymorphonuclear cells and mononuclear cells. This rotatory form of EAE may be a useful model for studying the neuropathological characteristics of multiple sclerosis affecting the brain stem and cerebellum.
Introduction
Experimental autoimmune encephalomyelitis (EAE) is an autoimmune disease of the nervous system which is widely studied as an animal model of the human demyelinating disease multiple sclerosis (MS) [26] . EAE can be induced by inoculation with an emulsion of whole spinal cord or brain, or whole or part of a myelin protein, in adjuvant (active EAE). For induction of EAE in mice, Bordetella pertussis toxin is often injected concurrently [9, 20, 21] . In passively induced EAE, T cells specific for myelin proteins are injected, with or without pertussis toxin. The most commonly used myelin proteins for the induction of EAE are myelin basic protein (MBP), which has been studied extensively (reviewed in [38] ), myelin proteolipid protein (PLP) [9, 11, 34] and myelin oligodendrocyte glycoprotein (MOG) [2, 15, 16] . Immunization with MBP results in demyelinated lesions in both the CNS and peripheral nervous system (PNS) [1, 4, 5, 25, 27, 28] , whereas EAE induced by PLP or MOG results in demyelinated lesions that are restricted to the central nervous system (CNS) [2, 4, 5, 9, 16] .
The characteristic clinical feature of EAE in mice and rats is ascending paralysis, commencing at the distal end of the tail and moving rostrally to affect the whole tail, hindlimbs and sometimes the forelimbs [6, 9, 17, 23, 31] . In these forms of EAE (ascending paralysis EAE), neuropathological analyses typically show that the CNS inflammatory and demyelinating lesions are located predominantly in the spinal cord [6, 24, 25, 31, 33] .
However, clinical signs other than ascending paralysis have also been described in some strains of mice when EAE is induced by PLP or MOG. In most strain/antigen combinations, the development of these atypical signs is not consistent, e.g., EAE induced in PL/J mice by MOG peptides [16] or in BALB/c mice by PLP [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [11] can cause forelimb paralysis in the absence of hindlimb paralysis or tail paralysis, and disturbances of balance in some animals, but the clinical signs vary from one animal to another.
CBA/J or C3H/HeJ mice immunized with PLP [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] or PLP 215-232 also develop an unusual form of EAE, but the clinical features of this form of EAE are reproducible in the majority of mice and always follow the same pattern. The initial neurological abnormality is the turning of the Diane M. Muller · Michael P. Pender · Judith M. Greer A neuropathological analysis of experimental autoimmune encephalomyelitis with predominant brain stem and cerebellar involvement and differences between active and passive induction head to one side. This head turning becomes more pronounced until at the most severe stage of disease the animal can not stand upright and rolls with an axial rotatory movement (rotatory EAE) [11] .
The present study was undertaken to explore further the features of axial rotatory EAE induced by PLP [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] in C3H/HeJ mice and to determine the neuropathological lesion distribution in mice showing these clinical signs. Firstly, we compared the clinical signs of actively versus passively induced disease. Next, we undertook a detailed histological analysis to elucidate the specific neural structures that are affected and to correlate the histopathology with the clinical neurological deficits. We report that mice that develop rotatory clinical signs have an increased concentration of inflammatory and demyelinated lesions within the brain stem and/or cerebellum, compared to mice that develop ascending paralysis. We also show that the distribution of lesions in rotatory EAE differs depending on whether EAE is induced by active immunization with PLP peptide or by passive transfer of T cells specific for the peptide. This rotatory EAE model will be useful for studying the neuropathological features of MS, particularly in those patients who have cerebellar and/or brain stem lesions.
Materials and methods

Mice
Female C3H/HeJ mice were purchased from the Animal Resources Centre, Perth, Western Australia. Mice were immunized at 8-10 weeks of age. All animals were maintained in accordance with the guidelines of the National Health and Medical Research Council of Australia.
PLP peptides PLP peptide 190-209 (SKTSASIGSLCADARMYGVL) was synthesized by Auspep (Melbourne, Australia) according to the human sequence [13] and was greater than 95% pure by high performance liquid chromatography (HPLC) and mass spectral analysis. This peptide is moderately hydrophobic and was dissolved at a concentration of 5 mg/ml in 0.2 M acetic acid prior to dilution in phosphate-buffered saline (PBS) or tissue culture medium.
Active induction of EAE
Mice were injected subcutaneously in the flank with 100 µg PLP 190-209 peptide and 400 µg Mycobacterium tuberculosis H37Ra (Difco Laboratories, Detroit) in an emulsion with complete Freund's adjuvant (CFA, Difco). The mice also received 300 ng pertussis toxin (List Biological Laboratories, Campbell, California) intravenously at the same time as the peptide and again 3 days later.
PLP 190-209 -specific T cell lines Mice were injected subcutaneously with 100 µg PLP 190-209 emulsified in CFA. After 10 days the inguinal and axillary lymph nodes were removed and stimulated with PLP [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] . The T cell lines were maintained in RPMI 1640 containing 10% fetal calf serum, 2 mM L-glutamine, 10 mM HEPES buffer and 50 µM 2-mercaptoethanol, and stimulated every 10-15 days with 5-10 µg/ml of the peptide using irradiated (2500 rad) spleen cells as antigen-presenting cells.
Passive induction of EAE After T cells had been stimulated in vitro four to five times, cells were harvested, the T cell blasts separated on a Ficoll gradient and washed. Five million to 10 million T cells specific for PLP [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] were injected intravenously into naïve C3H/HeJ mice. Some of the animals were also immunized intravenously with 300 ng pertussis toxin at the same time as the T cells and again 3 days later.
Clinical evaluation
Mice were weighed daily and assessed for clinical signs of EAE. Signs of ascending paralysis EAE were scored according to the following criteria: 0, no disease; 1, decreased tail tone or slightly clumsy gait; 2, tail atony and/or moderately clumsy gait and/or poor righting ability; 3, limb weakness; 4, limb paralysis; 5, moribund state. Signs of rotatory EAE were assessed as previously described [11] ; 0, no disease; 1, head turned slightly; 2, head turning more pronounced; 3, inability to walk in a straight line; 4, laying on side; 5, rolling continuously unless supported. Animals were killed at the peak of disease.
Histological evaluation
Animals were perfused with modified Karnovsky's fixative (2.0% paraformaldehyde, 2.5% glutaraldehyde, 2 mM CaCl 2 , 0.1 M cacodylate buffer pH 7.3), and the brain, optic nerves, spinal cord and cauda equina were removed. Tissue was post-fixed in Dalton's solution and embedded in Historesin (Leica Instruments, Heidelberg). Resin blocks were sectioned (1 µm) in the transverse plain every 25 µm and stained with cresyl fast violet [22] . Sections were examined for inflammatory lesions and demyelination at all levels of the CNS. Inflammation, rather than demyelination, was quantified, as the boundaries of inflammation were easily identified, whereas the exact extent of demyelination was often obscured by the presence of inflammatory cells. The size of the inflammatory lesions within these sections was also determined with an eyepiece graticule (10 × 10 grid), using a method similar to that employed by Vass et al. [36] . By moving the eyepiece graticule over each section in both the x and y planes measuring each area only once and counting the number of squares containing tissue in each area, the number of squares equivalent to the entire sectional area was calculated. To increase accuracy each square was subdivided into eight, and if one square was not completely filled by tissue, the number of one eighths of the square that were filled with tissue was added to the number of whole squares. This process was repeated, counting only the squares containing inflammatory lesions to calculate the percentage of lesions within each tissue section.
The results of analyses were grouped for specific areas of the CNS, based on the general pattern of lesions. An atlas of the mouse brain [8] was used to assist in the identification of anatomical structures. Area 1 extended from the optic nerve to the rostral appearance of the superior colliculus; area 2 extended from the superior colliculus to the rostral appearance of the sensory root of the trigeminal nerve; area 3 extended from the rostral appearance of the vestibular root of the vestibular nerve to the caudal termination of the facial nerve; area 4 extended from the caudal appearance of the vestibulocochlear nerve to the caudal termination of the trapezoid body; area 5 extended from the rostral appearance of the spinal trigeminal nuclei, interpolar, to the pyramidal decussation; area 6 comprised the entire cerebellum; area 7 extended from C1 to C8 of the spinal cord; area 8 extended from T1-T13; area 9 extended from L1 to L6; and area 10 extended from S1 to S4. The cauda equina was examined separately for possible PNS involvement.
Statistics
To assess statistical differences in lesional area at similar anatomical levels among groups of animals, an F test for analysis of variance was performed and, based on the results of this test, Student's t-test was performed. For each anatomical level of each animal, a section was analyzed every 100 µm. Thus, for each anatomical level, 36-48 sections were analyzed. Each section was included as a separate data point in the analysis of variance and the t-test. Results with a recorded P value of less than or equal to 0.05 were considered statistically significant. Table 1 shows, for each mouse tested, the method of induction of EAE, the day of onset of clinical signs of disease, the clinical score at the peak of disease, and the clinical features at the peak of disease. For animals that were perfused for histological analysis, the day on which they were perfused is also shown.
Results
Clinical observations
EAE was actively induced in 7 C3H/HeJ mice. All of these animals developed rotatory clinical signs, with no signs of weakness in any limbs or in the tail. The mean day of onset of clinical signs was 17.1 ± 6.7 days, and the mean clinical score was 4.2 ± 0.4. Onset of rotatory EAE was very rapid, with most mice changing from a normal clinical appearance to a score of 4 or 5 within 12 h.
Of the animals with passively induced EAE, 10 of 14 (71%) developed rotatory clinical signs with a mean day of onset (17.4 ± 7.1) and mean clinical score (4.6 ± 0.5) similar to those of mice with actively induced EAE. None of these animals showed signs of weakness in any limbs or in the tail. The other 4 mice with passively induced EAE developed clinical signs of ascending paralysis, i.e., signs of tail, hindlimb and forelimb weakness or paralysis. However, 1-2 days prior to the onset of these clinical signs, all showed signs of head turning slightly to one side. The head turning was no longer apparent upon development of signs of ascending paralysis. These 4 mice had an increased mean day of onset of EAE (25.5 ± 11.9) compared to animals that developed rotatory clinical signs but this difference was not significant (P = 0.359). Administration of pertussis toxin did not have a significant influence on the type of clinical signs that subsequently developed.
CNS tissues from 11 of the mice (Table 1) were subsequently studied by histological analysis. Mice that were not used for histological analysis were followed for up to 300 days after immunization. All these animals spontaneously relapsed, but the length of time between relapses varied from 10 to 30 days, and the clinical signs exhibited during relapses ranged from tail and/or limb paralysis to pronounced head turning and axial rotation. Tables 2 and 3 outline the average percentages of the transverse sectional area that were inflamed at each level of the CNS in each group of animals. In all animals, the inflammatory lesions were composed of polymorphonuclear cells and mononuclear cells. The polymorphonuclear cells predominated in the early stages of lesion development (Fig. 1 A) , whereas mononuclear cells predominated in established demyelinated lesions (Fig. 1 B) . The administration of pertussis toxin did not influence the cellular composition of inflammatory infiltrates. Inflammation was not restricted to areas of demyelination; however, the majority of inflammatory lesions did contain large numbers of demyelinated axons (Fig. 2) . In general, axons and nerve cell bodies were preserved but there was some evidence of axonal degeneration (Wallerian degeneration) in the dorsal columns of animals with spinal cord lesions and also in the brain stems of some animals (Fig. 3) .
Histological analyses of the CNS of C3H/HeJ mice from each group revealed a different spatial distribution of lesions in the mice with rotatory EAE compared to ascending paralysis EAE (Table 2 , Fig. 4 ) and in mice with passively induced rotatory EAE compared to actively induced rotatory EAE (Table 3 , Fig. 4) , as described below.
Cerebrum (area 1)
There was limited inflammation and demyelination in the cerebrum in all three groups (Tables 2, 3 ). Subpial infiltrates were observed surrounding the cerebrum, the optic chiasm and optic tract. In most animals there was also inflammation and demyelination in the parenchyma affecting the fibers of the optic chiasm and optic tracts.
Brain stem (areas 2-5)
The extent of lesions in the brain stem differed considerably among groups, but the vestibulocochlear nerve root entry zone was generally the most severely affected region (Fig. 1 B) . Animals with rotatory EAE had significantly more lesions within areas 2-5 in the brain stem, compared to animals with ascending paralysis EAE (P < 0.01) ( Table 2 ). In animals with passively induced rotatory EAE, the brain stem was the major site of involvement (Table 3) .
In the animals with passively induced rotatory EAE, lesions spanned the area from the brachium pontis along the ventrolateral white matter tracts of the brain stem to the lower medulla to give the appearance of an elongated confluent lesion. In the midbrain (area 2), the average area of inflammation within sections was 7.9% (maximum 27%). The brachium pontis, cerebral peduncle, middle cerebellar peduncle and the motor root of the trigeminal Table 2 Comparison of extent of inflammation in different anatomical areas of animals with rotatory or ascending paralysis EAE. The anatomical areas of the CNS designated 1-10 are described in detail in the Materials and methods section. a The percentage of transverse sectional area affected by inflammatory lesions in mice with rotatory forms of EAE is significantly greater than in mice with ascending paralysis EAE (P < 0.01) b The percentage of transverse sectional area affected by inflammatory lesions in mice with ascending paralysis EAE is significantly greater than in mice with rotatory forms of EAE (P < 0.001) nerve were affected. In the pons (area 3), the sensory root of the trigeminal nerve, ventral spinocerebellar tract, vestibular root of the vestibulochlear nerve and the anteroventral cochlear nuclei were also inflamed. The severity of the inflammation and demyelination increased caudally, affecting the vestibulocochlear nerve, trapezoid body, facial nerve and its root, olivocochlear bundle, spinal trigeminal tract, middle cerebellar peduncle, and the ventral cochlear nuclei. The lesions affected up to 19% of the transverse sectional area at this level with the average being 7.2%. In the upper medulla (area 4), the inferior cerebellar peduncle, vestibular nerve, and the spinal trigeminal tract were inflamed (average of 1.6% of the total section area). In addition, the central tissue projections of both the accessory and the hypoglossal nerves were inflamed and demyelinated. At the lower medulla (area 5), white matter adjacent to the area postrema was inflamed (average area of inflammation of 1.8%). Analysis of the CNS of animals with actively induced rotatory EAE or passively induced ascending paralysis EAE also showed inflammation and demyelination affecting some of the same structures within the brain stem as described for passively induced rotatory EAE, particularly the vestibulocochlear nerve root entry zone, trigeminal nerve and the cerebellar peduncles. However, the lesions were less extensive than those observed in passively induced rotatory EAE, with an average area of inflammation in the brain stem ranging from 0% to 1.6% of the total transverse section (Tables 2, 3) .
Cerebellum (area 6)
None of the mice with passively induced EAE showed any lesions in the cerebellum, regardless of their pattern of clinical signs (Tables 2, 3 ). In contrast, all animals with actively induced rotatory EAE had severe inflammatory and demyelinated lesions in the cerebellar white matter of all cerebellar lobules, particularly the fourth and fifth lob- (Table 3 ). In most cases the inflammation was perivascular, extending into the parenchyma, and, in some instances, forming confluent lesions (Fig. 5) . The maximum area of inflammation in these animals covered 11% of a transverse cerebellar section.
Spinal cord (areas 7-10)
The extent of spinal cord lesions in each group of mice increased caudally. The animals with rotatory EAE showed significantly less inflammation in the thoracic, lumbar and sacral spinal cord compared to animals with ascending paralysis EAE (P < 0.001).
In animals with ascending paralysis EAE (Table 2) , inflammation and demyelination were present in the dorsal root entry zones and ventral root exit zones throughout the entire spinal cord. There was inflammation and primary demyelination in the dorsal columns. In addition there was collapse or dilatation of many myelin sheaths in the dorsal columns, indicating axonal degeneration. The cervical spinal cord (area 7) was the least affected area, but the extent of lesions increased markedly in the thoracic spinal cord, with some sections showing inflammation and demyelination across the entire dorsal and/or ventral surface of the spinal cord. The average area of inflammation per transverse section at the thoracic level was 7.8%. The lumbar and sacral spinal cord showed severe confluent inflammation and demyelination encompassing almost all nerve fibre tracts. The average areas of inflammation in the lumbar and sacral spinal cord were 23.7% and 36.2%, respectively. Lesions affected up to 51% of the transverse sectional area in sacral spinal cord sections.
Mice with rotatory EAE had very few lesions in the cervical and thoracic spinal cord. On average, less than 0.5% of the total section area was inflamed at any given level, and any lesions that were present were restricted to either the root entry/exit zones (the central tissue projection being most severely affected), or the dorsal columns. The dorsal columns of the rostral spinal cord segments also contained some collapsed or dilated myelin sheaths. Lesions in the lumbar and sacral cord were also concentrated around the root entry/exit zones, but some confluent lesions affecting all superficial surfaces also occurred in these animals. In the lumbar cord the mean transverse sectional area encompassed by lesions was 1.0% in rotatory EAE. In the sacral cord this percentage rose to 6.7% (Table 2) .
Examination of the cauda equina revealed that there were no inflammatory or demyelinated lesions in the spinal roots of the PNS.
Discussion
This study demonstrates that a form of EAE, induced by injection of PLP [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] or T cells specific for this peptide, and characterized clinically by axial rotation, shows significant histological differences from the ascending paralysis form of murine EAE. The major sites of inflammatory and demyelinated lesions in mice with severe axial rotation were the cerebellum and brain stem, depending upon whether EAE was actively or passively induced, respectively. In contrast, mice that developed ascending paralysis EAE had the greatest concentration of lesions in the spinal cord, especially in the lumbosacral regions, as has previously been reported for ascending paralysis forms of EAE [6, 24, 31, 33] .
The axial rotation observed in the mice is most likely due to involvement of the vestibular pathways in the brain stem and/or cerebellum. The clinical deficits could be explained either by primary demyelination and/or axonal degeneration of the primary sensory neurons of the vestibular nerve in the CNS or by damage in a postsynaptic pathway between the vestibular nuclei and the cerebellum, e.g., inferior cerebellar peduncle. Only one other study of EAE in mice has reported clinical signs similar to those in our study. Endoh et al. [7] observed axial rotation in BALB/cCr mice after induction of EAE with DM20, an alternatively spliced isoform of PLP; however, they reported that lesions within the brain stem and cerebellum were uncommon. In the BALB/cCr mice, loss of tail tone always preceded the axial rotation, whereas in our study the loss of balance resulting in rotatory movements was the first sign of EAE and occurred in the absence of tail or limb weakness.
The cellular composition of the inflammatory infiltrates in C3H/HeJ mice with EAE is of interest, in that polymorphonuclear cells made up a large percentage of the cells infiltrating the parenchyma in the early lesions. This is similar to that seen in hyperacute EAE in the Lewis rat, where there is a major neutrophilic infiltrate [19] , and to that reported in early EAE studies in mice [29] . The abundance of polymorphonuclear cells in the infiltrate in C3H/HeJ mice could be due to different pro-inflammatory cytokines/chemokines being induced in different mouse strains. Alternatively, it could be a matter of timing. In normal inflammatory responses, polymorphonuclear cells and mononuclear cells are rapidly attracted to the site of inflammation; however, the polymorphonuclear cells are lost from the site within 24-48 h, whereas the mononuclear cells persist [14] . Because of the rapid onset of clinical signs in the mice used in the current study, most mice were studied histologically on the day of onset of clinical signs and may, therefore, have been more likely to have polymorphonuclear cell infiltrates.
There are several possible explanations for the relative restriction of lesions to the brain stem and cerebellum in C3H/HeJ mice that developed rotatory clinical signs. One possibility is that the target antigen, PLP [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] , varies in its distribution or accessibility within the CNS. Although it is known that PLP is distributed throughout CNS myelin, there is evidence that oligodendrocytes that myelinate different regions of the CNS can originate at different times during development [32] and that the biochemical and physical properties of oligodendrocytes differ, depending on where they are situated in the CNS [3, 18] . Another possibility is that the C3H/HeJ strain of mice differs from other strains in the concentration of professional antigen-presenting cells or in the expression of major histocompatibility complex molecules in certain areas. If the antigen ) were more successfully processed or presented to T cells entering the CNS in a particular area, there could be increased inflammation in that area. These possibilities are currently being investigated. It seems unlikely that the relative restriction of lesions is due to increased permeability of the blood-brain barrier of the brain stem and cerebellum of these mice, particularly in view of the different distribution of lesions in actively induced EAE compared to passively induced EAE.
These differences in lesion distribution and clinical signs in mice with actively induced EAE compared to those with passively induced EAE are of particular interest. EAE induced by PLP or MBP can be transferred by T cells alone. However, the differences we observe between passively induced EAE and actively induced EAE suggest that some factor in actively immunized mice influences both the clinical signs and lesion distribution. A potential candidate is PLP peptide-specific antibody, which is present in high titer in all actively immunized mice, but is undetectable in mice with passively transferred EAE (Greer, unpublished data) . Immunohistochemical studies with cultured oligodendrocytes have shown that the orientation of PLP in the myelin membrane is such that the 190-209 region of the molecule would lie on the external face of the myelin membrane [10] , and would therefore be accessible to antibody attack. If the 190-209 region of PLP in the cerebellum were more accessible to antibody attack, this could account for the lesion distribution in actively induced EAE. Alternatively, anti-PLP antibody might cross-react with some other cerebellar component, such as the PLP homologue M6, which is expressed particularly strongly in the cerebellum [37] .
This rotatory form of EAE may be a useful model for studying MS. Firstly, the differences in clinical signs and histology between active and passive disease suggest that antibody is important. Secondly, this is a good model for examining brain stem and cerebellar involvement in MS, which is quite common [30] , particularly in patients with more advanced disease. Interestingly, we have recently found that MS patients with relapsing-remitting or secondary progressive disease show increased T cell reactivity to the PLP 190-209 peptide and an overlapping peptide PLP [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [12] . This reactivity was particularly increased in patients with a disease duration of between 5 and 15 years. Tuohy et al. [35] also recently showed that two out of three patients with anterior brain stem syndrome responded to PLP peptides within the 190-209 region. It is interesting to speculate whether development of reactivity to this region of PLP may predispose towards development of lesions in these anatomical areas.
